You searched for side effects - Page 55 of 311 - Medivizor
Navigation Menu

Copanlisib plus rituximab improves survival in patients with relapsed painless non-Hodgkin lymphoma.

Copanlisib plus rituximab improves survival in patients with relapsed painless non-Hodgkin lymphoma.

Posted by on May 22, 2021 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study reported the effectiveness and safety outcomes of copanlisib (Aliqopa) and rituximab (Rituxan) combination for the treatment of patients with relapsed indolent (painless) non-Hodgkin lymphoma (NHL). The data showed that this combination improved the outcomes of these patients with manageable side effects. Some background...

Read More

Evaluating the effectiveness and safety of different regimens of containing pegylated liposomal doxorubicin in patients with newly diagnosed multiple myeloma.

Evaluating the effectiveness and safety of different regimens of containing pegylated liposomal doxorubicin in patients with newly diagnosed multiple myeloma.

Posted by on May 22, 2021 in Multiple Myeloma | 0 comments

In a nutshell This study investigated the effectiveness and safety of different regimens containing pegylated liposomal doxorubicin (PLD; Doxil) for patients with newly diagnosed multiple myeloma (NDMM). The data showed that the different PLD treatment regimens had promising effectiveness with manageable side effects. Some background Multiple...

Read More

Should radiotherapy be given at the same time or after chemotherapy for patients with advanced non-small cell lung cancer?

Should radiotherapy be given at the same time or after chemotherapy for patients with advanced non-small cell lung cancer?

Posted by on May 22, 2021 in Lung cancer | 0 comments

In a nutshell This study investigated the effectiveness and safety outcomes of radiotherapy given at the same time (concurrent chemoradiotherapy; cCRT) or after chemotherapy (sequential chemoradiotherapy; sCRT) for the treatment of patients with advanced non-small-cell lung cancer (NSCLC). The data showed that cCRT improved the long-term...

Read More

Evaluation of intermittent androgen deprivation therapy for locally advanced prostate cancer.

Evaluation of intermittent androgen deprivation therapy for locally advanced prostate cancer.

Posted by on May 19, 2021 in Prostate cancer | 0 comments

In a nutshell The study compared patient-reported outcomes (PRO) in patients receiving continuous androgen deprivation therapy (CADT) vs intermittent androgen deprivation therapy (IADT) for locally advanced prostate cancer (PCa). The study reported that PROs were significantly improved with IADT. Some background ADT is a hormonal therapy...

Read More

Evaluating single injection of OnabotulinumtoxinA into the bladder trigone for the treatment of overactive bladder

Evaluating single injection of OnabotulinumtoxinA into the bladder trigone for the treatment of overactive bladder

Posted by on May 16, 2021 in Overactive bladder | 0 comments

In a nutshell This study compared the safety and durability of one injection of OnabotulinumtoxinA (Botox; OBT-A) in the bladder trigone vs 20 injections avoiding this region for the treatment of overactive bladder (OAB). Researchers suggested that one OBT-A trigone injection is a safe and durable treatment option for these patients. Some...

Read More

Chemotherapy delivered directly in the liver in patients with colorectal cancer that has spread to the liver.

Chemotherapy delivered directly in the liver in patients with colorectal cancer that has spread to the liver.

Posted by on May 16, 2021 in Colorectal cancer | 0 comments

In a nutshell The aim of this study was to evaluate if hepatic arterial infusion chemotherapy (HAIC) could be beneficial for patients with colorectal cancer (CRC) that has spread to the liver (liver metastasis; LM). The study found that HAIC improved the outcome of these patients. Some background CRC is one of the most common types of cancer...

Read More

Improving the mental health and quality of life of patients with colorectal cancer.

Improving the mental health and quality of life of patients with colorectal cancer.

Posted by on May 16, 2021 in Colorectal cancer | 0 comments

In a nutshell This study evaluated the impact of non-drug therapy on the quality of life (QoL) of patients with colorectal cancer (CRC). The study found that non-drug therapies such as psychological, social, and physical activities were associated with reduced anxiety, depression, and improved QoL. Some background CRC is one of the most...

Read More

Adding isatuximab to pomalidomide-dexamethasone therapy for relapsed/refractory multiple myeloma.

Adding isatuximab to pomalidomide-dexamethasone therapy for relapsed/refractory multiple myeloma.

Posted by on May 16, 2021 in Multiple Myeloma | 0 comments

In a nutshell The aim of this study was to evaluate the addition of isatuximab (Sarclisa) to pomalidomide (Pomalyst) and dexamethasone (Decadron) therapy for patients with relapsed/refractory (r/r) multiple myeloma (MM). The study found that patients who were given isatuximab had a better outcome. Some background MM is a type of blood cancer...

Read More

Evaluating the effectiveness and safety a second radiation therapy in patients with prostate cancer.

Evaluating the effectiveness and safety a second radiation therapy in patients with prostate cancer.

Posted by on May 16, 2021 in Prostate cancer | 0 comments

In a nutshell This study investigated the effectiveness and safety of re-irradiation in the treatment of patients with relapsed prostate cancer (PCa). The data showed that the use of re-irradiation in these patients was associated with good outcomes and low toxicity. Some background Radiotherapy (RT) is an effective treatment for localized prostate...

Read More

Could immune-related adverse events predict the effectiveness of immune checkpoint inhibitors in patients with lung cancer?

Could immune-related adverse events predict the effectiveness of immune checkpoint inhibitors in patients with lung cancer?

Posted by on May 16, 2021 in Lung cancer | 0 comments

In a nutshell This study investigated whether immune-related side effects (irSEs) could predict the effectiveness of immune checkpoint inhibitors (ICIs) in patients with lung cancer. The data showed that the occurrence of skin, hormone, and gastrointestinal irSEs could predict the effectiveness of immunotherapy in these patients. Some background...

Read More

Comparing 2 radiation treatments for elderly women with low-risk breast cancer

Comparing 2 radiation treatments for elderly women with low-risk breast cancer

Posted by on May 15, 2021 in Breast cancer | 0 comments

In a nutshell This article compared the outcomes of older patients with low-risk breast cancer treated with accelerated partial breast irradiation (APBI) or ultra-APBI. The authors found that both treatment methods resulted in similar outcomes and side effects in these patients.  Some background Breast cancer is the most commonly diagnosed...

Read More